A
Amneal Oncology Pvt., Ltd.
Amneal, founded in 2002 and headquartered in Bridgewater, New Jersey, operates as a pharmaceutical company, developing, manufacturing, marketing, and distributing generic and biosimilar pharmaceutical products.
Country/Area ：India
Company Email ：hr@amneal.com
Industry ：HealthcarePharmaceuticals
Company website ：*****
Company phone ：(908) 947-3120
Established ：2002
Company Revenue ：$2,212,304,000
Number of employees ：7600
SIC Code ：28283
NAICS Code ：32325
Main Products ：Research & Development We invest significantly in new product developmentGenerics ProductsVoices of LeadershipExecutive Officers & DirectorsMedical InquiriesNABP DDA AccreditationWeb AccessibilityRise, Lead, SucceedSEC FilingsQuarterly & Other ReportsBiosciences ProductsAdverse Event ReportingCopyright & Legal DisclaimerSpecialty ProductsAnnual ReportsTotal RewardsBoard Committees
Company News
Amneal Reports Third Quarter 2023 Financial Results
Nov 7, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced its results today for the third quarter ended September 30, 2023. “We are pleased to report strong double-digit revenue and adjusted EBITDA growth for the third quarter and raise our full year guidance. The acceleration in our growth is a testament to the strong execution of our strategy, the success of our new launches and the continued diversification of our portfolio. We are
Nov 7, 2023
Amneal Pharmaceuticals (NYSE:AMRX) delivers shareholders decent 83% return over 1 year, surging 11% in the last week aloneNov 6, 2023
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can...
Nov 6, 2023JPMorgan Overhauls Loan for Amneal Pharmaceuticals After Investor BacklashNov 3, 2023
(Bloomberg) -- A leveraged loan deal from Amneal Pharmaceuticals LLC has been revamped after facing investor pushback.Most Read from BloombergAmazon’s Jeff Bezos Announces Move to Miami From SeattleSam Bankman-Fried Convicted of Fraud in Stunning FTX CrashHedge Fund Executive’s Sudden Death Exposes a Firm Deep in TroubleApple Warns of Sluggish Holiday Quarter After China SlowdownHarvard, Yale Warned by Top Law Firms About AntisemitismJPMorgan Chase & Co., which is leading the proposed transactio
Nov 3, 2023Amneal to Participate at Upcoming Investor ConferencesNov 3, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the below investor conferences. Jefferies 14th Annual Global Healthcare Conference November 14, 2023 London, UK Presentation – 8:30 AM GMT Piper Sandler 35th Annual Healthcare Conference November 28, 2023 New York, New York Presentation – 9:00 AM EST A live webcast of the prese
Nov 3, 2023Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial GuidanceOct 23, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced certain unaudited preliminary financial results for the third quarter ended September 30, 2023. The Company also raised its financial guidance for the year ending December 31, 2023, which was most recently issued on August 4, 2023. The Company plans to report actual third quarter 2023 financial results on November 7, 2023. Unaudited Preliminary Financial Results for the Thir
Oct 23, 2023Business Info
CIN ：U24230GJ1998PTC084755
Registered State ：Gujarat
Registrar Of Companies ：RoC-Ahmedabad
Category ：Company limited by Shares
Sub Category ：Non-govt company
Company Class ：Private
Company Status ：Active
Registered Office Address ：882/1-871, SARKHEJ BAVLA HIGHWAY, NEAR HOTEL KANKAVATI,VILAAGE-RAJODA, BAVLA AHMEDABAD Ahmedabad GJ IN 382220
Authorized Cap ：350000000.00
Paidup Capital ：336513690.00
Web Summary
Q1: What is the address of Amneal Oncology Pvt., Ltd.?
A1: The company's headquarters is located at 118 Beaver Trail, 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ 08807.
Q2: What types of products does Amneal create and manufacture?
A2: Amneal creates essential medicines, including hard gelatin capsules, oral solids, suspensions/solutions, ointments, creams, and other dosage forms. They also develop injectable products that are important to healthcare providers and patients.
Q3: In which industry is Amneal primarily involved?
A3: Amneal is primarily involved in the pharmaceutical industry, specifically in the development, manufacturing, and distribution of generic and specialty pharmaceuticals.
Q4: What services does Amneal offer to its customers?
A4: Amneal offers sales and customer relations services, as well as product complaints and adverse event reporting. They also provide compliance and ethics guidance, including a corporate code of conduct and a whistleblower policy.
Q5: How can one contact Amneal for business inquiries or other purposes?
A5: One can contact Amneal through their website, email (BusinessDevelopment@amneal.com), phone (908) 9473120, or fax (908) 9473146. They also have a LinkedIn page and Twitter account.
Q6: What is the company's commitment to ethics and compliance?
A6: Amneal has a corporate code of conduct that defines the guiding principles by which all employees drive their business and earn the trust of countless patients. The company adheres to the highest ethical business standards as well as all applicable laws and regulations.
Q7: How many generic and specialty pharmaceuticals does Amneal manufacture?
A7: Amneal manufactures over 280 generic and specialty pharmaceuticals, with a growing portfolio in core therapeutic categories including neurology (Parkinson’s Disease, Migraine), endocrinology (Hypothyroidism), and other therapeutic areas.
Q8: What is the company's commitment to sustainability and social responsibility?
A8: Amneal has made a commitment to embedding sustainability across its business, as well as prioritizing human capital management, philanthropic partnerships with healthrelated nonprofits, corporate governance, and improving access to essential medicines globally.
A1: The company's headquarters is located at 118 Beaver Trail, 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ 08807.
Q2: What types of products does Amneal create and manufacture?
A2: Amneal creates essential medicines, including hard gelatin capsules, oral solids, suspensions/solutions, ointments, creams, and other dosage forms. They also develop injectable products that are important to healthcare providers and patients.
Q3: In which industry is Amneal primarily involved?
A3: Amneal is primarily involved in the pharmaceutical industry, specifically in the development, manufacturing, and distribution of generic and specialty pharmaceuticals.
Q4: What services does Amneal offer to its customers?
A4: Amneal offers sales and customer relations services, as well as product complaints and adverse event reporting. They also provide compliance and ethics guidance, including a corporate code of conduct and a whistleblower policy.
Q5: How can one contact Amneal for business inquiries or other purposes?
A5: One can contact Amneal through their website, email (BusinessDevelopment@amneal.com), phone (908) 9473120, or fax (908) 9473146. They also have a LinkedIn page and Twitter account.
Q6: What is the company's commitment to ethics and compliance?
A6: Amneal has a corporate code of conduct that defines the guiding principles by which all employees drive their business and earn the trust of countless patients. The company adheres to the highest ethical business standards as well as all applicable laws and regulations.
Q7: How many generic and specialty pharmaceuticals does Amneal manufacture?
A7: Amneal manufactures over 280 generic and specialty pharmaceuticals, with a growing portfolio in core therapeutic categories including neurology (Parkinson’s Disease, Migraine), endocrinology (Hypothyroidism), and other therapeutic areas.
Q8: What is the company's commitment to sustainability and social responsibility?
A8: Amneal has made a commitment to embedding sustainability across its business, as well as prioritizing human capital management, philanthropic partnerships with healthrelated nonprofits, corporate governance, and improving access to essential medicines globally.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
